CIK 0001022079 · Large accelerated filer
QUEST DIAGNOSTICS INC
Sign in to watch- Ticker
- DGX
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 161387862
- Phone
- 9735202700
- Business address
- 500 PLAZA DRIVE, SECAUCUS, NJ, 07094
- Former names
- CORNING CLINICAL LABORATORIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $16,730,307
- in 5 filings, $16.7M under 10b5-1 plans
Net −$16,730,307. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- PREVOZNIK MICHAEL E −$5.5M SVP & General Counsel sold 38% of stake
- Doherty Catherine T. −$5.5M Executive Vice President sold 24% of stake
- Plewman Patrick −$3.0M SVP for Diagnostic Services sold 44% of stake
- Davis J. E. −$2.4M CEO and President sold 8% of stake
- PFEIFFER GARY M −$292K Director sold 4% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-14 | Plewman Patrick SVP for Diagnostic Services | Grant or award | +2,446 | 15,035 | ||
| 2024-02-14 | Plewman Patrick SVP for Diagnostic Services | Grant or award · Non-Qualifed Stock Option (right to buy) | +10,190 | 10,190 | ||
| 2024-02-14 | PREVOZNIK MICHAEL E SVP & General Counsel | Grant or award | +2,935 | 41,274 | ||
| 2024-02-14 | PREVOZNIK MICHAEL E SVP & General Counsel | Grant or award · Non-Qualifed Stock Option (right to buy) | +12,231 | 12,231 | ||
| 2024-02-14 | SAMAD SAM Executive Vice President & CFO | Grant or award | +5,478 | 21,988 | ||
| 2024-02-14 | SAMAD SAM Executive Vice President & CFO | Grant or award · Non-Qualifed Stock Option (right to buy) | +22,835 | 22,835 | ||
| 2024-02-14 | KUPPUSAMY KARTHIK SVP, Clinical Solutions | Grant or award | +2,641 | 14,079 | ||
| 2024-02-14 | KUPPUSAMY KARTHIK SVP, Clinical Solutions | Grant or award · Non-Qualifed Stock Option (right to buy) | +11,007 | 11,007 | ||
| 2024-02-14 | DELANEY MARK E SVP & Chief Commercial Officer | Grant or award | +2,348 | 5,828 | ||
| 2024-02-14 | DELANEY MARK E SVP & Chief Commercial Officer | Grant or award · Non-Qualifed Stock Option (right to buy) | +9,783 | 9,783 | ||
| 2024-02-14 | Doherty Catherine T. SVP, Regional Businesses | Grant or award | +4,304 | 72,114 | ||
| 2024-02-14 | Doherty Catherine T. SVP, Regional Businesses | Grant or award · Non-Qualifed Stock Option (right to buy) | +17,939 | 17,939 | ||
| 2024-02-14 | DEPPE MICHAEL J SVP, Corp. Controller & CAO | Grant or award | +558 | 34,070 | ||
| 2024-02-14 | DEPPE MICHAEL J SVP, Corp. Controller & CAO | Grant or award · Non-Qualifed Stock Option (right to buy) | +2,322 | 2,322 | ||
| 2024-01-31 | Gregg Vicky B Director | Grant or award | +88 | $129.33 | $11K | 18,829 |
| 2024-01-31 | SAMAD SAM Executive Vice President & CFO | Grant or award | +17 | $129.33 | $2K | 16,510 |
| 2024-01-31 | KUPPUSAMY KARTHIK SVP, Clinical Solutions | Grant or award | +29 | $129.33 | $4K | 11,438 |
| 2024-01-31 | Plewman Patrick SVP for Diagnostic Services | Grant or award | +50 | $129.33 | $6K | 12,589 |
| 2024-01-02 | RING TIMOTHY M Director | Grant or award · Phantom Stock Units | +294 | 14,581.65 | ||
| 2023-10-23 | Gregg Vicky B Director | Grant or award | +92 | $122.86 | $11K | 18,741 |
Page 22 of 29 · 563 trades